Ascendis Pharma A/S (ASND)
NASDAQ: ASND
· Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT
Ascendis Pharma A/S Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -341.68M | -378.08M | -426.49M | -489.52M | -501.57M | -481.45M | -601.99M | -608.72M | -568.61M | -583.19M | -481.84M | -393.23M | -446.28M | -383.58M | -416.48M | -457.87M | -418.43M |
Depreciation & Amortization | 17.78M | 17.71M | 18.22M | 18.59M | 18.84M | 18.91M | 18.57M | 18.34M | 18.09M | 17.96M | 17.59M | 16.86M | 16.09M | 15.39M | 14.1M | 12.59M | 11.17M |
Stock-Based Compensation | 103.74M | 95.47M | 85.15M | 76.37M | 70.25M | 66.66M | 64.63M | 60.98M | 57.9M | 64.18M | 64.45M | 64.2M | 63.72M | 66.83M | 67.07M | 64.2M | 61.3M |
Other Working Capital | 99.3M | 110.95M | 22.9M | 32.51M | 23.81M | -2.21M | -23.57M | -18.07M | -13.53M | -5.45M | -16.56M | -46.42M | -56.84M | -28.78M | -30.2M | -2.97M | 26.41M |
Other Non-Cash Items | -39.13M | 54.53M | 123.57M | 162.62M | 99.49M | 21M | 38.29M | 26.66M | -10.01M | 18.6M | -37.11M | -81.05M | -6.41M | -67.01M | -18.9M | 39.37M | 33.51M |
Deferred Income Tax | 2.11M | 4.61M | 9.32M | 8.94M | 8.51M | 7.3M | 6.86M | 6.05M | 6.43M | 5.38M | -86K | 87K | 65K | -367K | -270K | -295K | -333K |
Change in Working Capital | 38.24M | -108.64M | -79.46M | -115.29M | -125.64M | -99.79M | -92.93M | -44M | -15.76M | -18.62M | -40.34M | -82.89M | -94M | -48.91M | -30.2M | -2.97M | 26.41M |
Operating Cash Flow | -218.93M | -306.2M | -261.49M | -330.08M | -421.9M | -467.36M | -566.58M | -540.69M | -511.95M | -495.7M | -477.32M | -476.01M | -466.82M | -417.65M | -384.67M | -344.97M | -286.38M |
Capital Expenditures | -1.93M | -1.43M | -981K | -1.45M | -1.56M | -2.44M | -6.29M | -8.47M | -11.76M | -14.49M | -15.5M | -23.64M | -23.5M | -24.23M | -24.66M | -18.65M | -19.97M |
Cash Acquisitions | n/a | n/a | 4.28K | 51.63K | 51.63K | 51.63K | 9.52M | 9.17M | 15.08M | 18.93M | 9.45M | 9.75M | 3.85M | -10.19M | -9.23M | -9.23M | -9.23M |
Purchase of Investments | n/a | n/a | -4.28K | -51.63K | -51.63K | -51.63K | -53.05M | -124.14M | -187.53M | -213.84M | -299.33M | -239.38M | -212.91M | -226.04M | -284.9M | -380.66M | -343.75M |
Sales Maturities Of Investments | -1K | 7.35M | 13.94M | 37.09M | 84.49M | 288.87M | 338.27M | 403.52M | 427.38M | 280.53M | 255.91M | 210.42M | 190.69M | 149.88M | 248.91M | 206M | 154.47M |
Other Investing Acitivies | 950K | 8.3M | 8.27M | 8.36M | 54.81M | 259.18M | 249.7M | 249.96M | 202.39M | -5.54M | -103.2M | -71.77M | -56.99M | -86.88M | 20.34M | 125.27M | -122.79M |
Investing Cash Flow | -982K | 6.88M | 13.91M | 36.63M | 82.98M | 286.47M | 279.03M | 270.9M | 233.84M | 61.73M | -49.39M | -43.07M | -41.92M | -110.58M | -69.79M | -65.8M | -315.18M |
Debt Repayment | 122.51M | 122.79M | 119.48M | 125.3M | 125.6M | 125.82M | 130.3M | -8.28M | -8.15M | 496.93M | 497.16M | 497.06M | 498.04M | -6.43M | -6.18M | -5.84M | -5.62M |
Common Stock Repurchased | -28.79M | n/a | -1.81M | -1.81M | -1.81M | -1.81M | -2K | -1K | -151K | -105.31M | -126.91M | -126.91M | -126.76M | -21.61M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 294.47M | 301.85M | 318.31M | 27.97M | 27.82M | 8.47M | 11.4M | 6.54M | 6.63M | 5.15M | 4.35M | 7.44M | 9.94M | 11.54M | 9.21M | -26.59M | -29.39M |
Financial Cash Flow | 407.48M | 443.93M | 437.79M | 153.27M | 153.42M | 134.29M | 141.7M | -1.74M | -1.66M | 396.77M | 374.8M | 745.48M | 749.1M | 351.39M | 382.33M | 596.39M | 603.79M |
Net Cash Flow | 197.68M | 167.38M | 184.25M | -135.53M | -181.04M | -52.6M | -167.06M | -278.17M | -254.36M | -1.5M | -84.61M | 287.85M | 260.6M | -138.25M | -70.51M | 143.93M | -39.33M |
Free Cash Flow | -220.86M | -307.62M | -262.47M | -331.53M | -423.45M | -469.8M | -572.86M | -549.16M | -523.71M | -510.19M | -492.83M | -499.65M | -490.31M | -441.88M | -409.33M | -363.62M | -306.35M |